Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic

Scott Dryden-Peterson; Gustavo E Velásquez; Thomas J Stopka; Sonya Davey; Shahin Lockman; Bisola O Ojikutu

doi:10.1001/jamanetworkopen.2020.37067

Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic

JAMA Netw Open. 2021 Feb 1;4(2):e2037067. doi: 10.1001/jamanetworkopen.2020.37067.

Authors

Scott Dryden-Peterson^{1

2

3}, Gustavo E Velásquez^{1

4

5}, Thomas J Stopka^{6

7}, Sonya Davey⁸, Shahin Lockman^{1

2

3}, Bisola O Ojikutu^{1

4}

Affiliations

¹ Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
³ Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
⁴ Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
⁵ Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
⁶ Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts.
⁷ Tufts Clinical and Translational Science Institute, Boston, Massachusetts.
⁸ Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Abstract

This cohort study examines disparities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing during the coronavirus disease 2019 (COVID-19) pandemic in Massachusetts.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

COVID-19 / diagnosis*
COVID-19 / epidemiology
COVID-19 Testing* / statistics & numerical data
Health Equity*
Healthcare Disparities*
Humans
Massachusetts / epidemiology
Pandemics*
Patient Acceptance of Health Care
SARS-CoV-2
Social Class*

Abstract

Publication types

MeSH terms

Grants and funding